{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T03:19:11Z","timestamp":1782011951910,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T00:00:00Z","timestamp":1437091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T00:00:00Z","timestamp":1437091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The rapid clinical translation of mesenchymal stem cells (MSC) has resulted in the development of cell-based strategies for multiple indications. Unfortunately one major barrier to widespread implementation of MSC-based therapies is the limited supply of fetal calf serum (FCS) used to expand cells to therapeutic numbers. Additionally, the xenogeneic element of fetal calf serum has been previously demonstrated to stimulate antibody mediated reactions and in some cases sensitization leading to anaphylaxis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method<\/jats:title>\n            <jats:p>XcytePLUS\u2122 media, a human platelet lysate based product, was used to supplement the culture medium at 5, 7.5 and 10% and compared to fetal calf serum at 10%, for human umbilical cord MSC expansion. Properties of the expanded cells were investigated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>This study demonstrated equivalent or superior effects of human platelet lysate compared to standard FCS supplemented media, based on doubling rate, without loss of identity or function, as demonstrated with flow cytometry characterization. Differentiation into osteocytes, adipocytes and chondrocytes was comparable from cells expanded in either media supplement.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>These data support the implementation of human platelet lysate supplemented media as an alternative to xenogeneic containing preparations which may lead to safer MSC products with therapeutic uses.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12967-015-0561-6","type":"journal-article","created":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T09:37:05Z","timestamp":1437039425000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Scalable efficient expansion of mesenchymal stem cells in xeno free media using commercially available reagents"],"prefix":"10.1186","volume":"13","author":[{"given":"Neil H","family":"Riordan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialaura","family":"Madrigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Reneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathya","family":"de Cupeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelsy","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E","family":"Ichim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit N","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,17]]},"reference":[{"issue":"5","key":"561_CR1","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1084\/jem.15.5.516","volume":"15","author":"A Carrel","year":"1912","unstructured":"Carrel A (1912) On the permanent life of tissues outside of the organism. J Exp Med 15(5):516\u2013528","journal-title":"J Exp Med"},{"issue":"2","key":"561_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0014-4827(72)90390-4","volume":"74","author":"M Shodell","year":"1972","unstructured":"Shodell M, Rubin H, Gerhart J (1972) Neutralization of growth-inhibitory material present in calf serum by conditioning factors elaborated by chick embryo cells in culture. Exp Cell Res 74(2):375\u2013382","journal-title":"Exp Cell Res"},{"issue":"18","key":"561_CR3","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1001\/jama.1983.03330420074041","volume":"249","author":"ED Thomas","year":"1983","unstructured":"Thomas ED (1983) Bone marrow transplantation. A lifesaving applied art. An interview with E. Donnall Thomas, MD. JAMA 249(18):2528\u20132536","journal-title":"JAMA"},{"issue":"3","key":"561_CR4","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1182\/blood.V89.3.776","volume":"89","author":"TA Selvaggi","year":"1997","unstructured":"Selvaggi TA, Walker RE, Fleisher TA (1997) Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 89(3):776\u2013779","journal-title":"Blood"},{"issue":"4","key":"561_CR5","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/jnci\/52.4.1051","volume":"52","author":"RF Irie","year":"1974","unstructured":"Irie RF, Irie K, Morton DL (1974) Natural antibody in human serum to a neoantigen in human cultured cells grown in fetal bovine serum. J Natl Cancer Inst 52(4):1051\u20131058","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"561_CR6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/0091-6749(89)90099-7","volume":"83","author":"E Macy","year":"1989","unstructured":"Macy E et al (1989) Anaphylaxis to infusion of autologous bone marrow: an apparent reaction to self, mediated by IgE antibody to bovine serum albumin. J Allergy Clin Immunol 83(5):871\u2013875","journal-title":"J Allergy Clin Immunol"},{"key":"561_CR7","doi-asserted-by":"crossref","unstructured":"Mackensen A, Drager R, Schlesier M, Mertelsmann R, Lindemann A (2000) Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells. Cancer Immunol 49(3):152\u2013156","DOI":"10.1007\/s002620050614"},{"key":"561_CR8","doi-asserted-by":"crossref","unstructured":"Kadri N, Potiron N, Ouary M, Jegou D, Gouin E, Bach JM et al (2007) Fetal calf serum-primed dendritic cells induce a strong anti-fetal calf serum immune response and diabetes protection in the non-obese diabetic mouse. Immunol Lett 108(2):129\u2013136","DOI":"10.1016\/j.imlet.2006.11.007"},{"issue":"6","key":"561_CR9","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.4049\/jimmunol.116.6.1561","volume":"116","author":"G Forni","year":"1976","unstructured":"Forni G, Green I (1976) Heterologous sera: a target for in vitro cell-mediated cytotoxicity. J Immunol 116(6):1561\u20131565","journal-title":"J Immunol"},{"key":"561_CR10","unstructured":"Lauer SJ, Finlan J, Borella LD, Piaskowski VD, Casper JT (1983) In vitro enhancement of peripheral blood mononuclear cell natural killer activity following short term incubation with fetal calf serum. J Clin Lab Immunol 12(2):105\u2013110"},{"issue":"2","key":"561_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.beha.2010.04.001","volume":"23","author":"H Arien-Zakay","year":"2010","unstructured":"Arien-Zakay H, Lazarovici P, Nagler A (2010) Tissue regeneration potential in human umbilical cord blood. Best Pract Res Clin Haematol 23(2):291\u2013303","journal-title":"Best Pract Res Clin Haematol"},{"key":"561_CR12","doi-asserted-by":"crossref","unstructured":"Obermajer N, Popp FC, Johnson CL, Benseler V, Dahlke MH (2014) Rationale and prospects of mesenchymal stem cell therapy for liver transplantation. Curr Opinion Organ Transplant 19(1):60\u201364","DOI":"10.1097\/MOT.0000000000000031"},{"key":"561_CR13","doi-asserted-by":"crossref","unstructured":"Hu J, Yu X, Wang Z, Wang F, Wang L, Gao H et al (2013) Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. Endocrine J 60(3):347\u2013357","DOI":"10.1507\/endocrj.EJ12-0343"},{"key":"561_CR14","doi-asserted-by":"publisher","unstructured":"Huo W, Liu X, Tan C, Han Y, Kang C, Quan W et al (2014) Stem cell transplantation for treating stroke: status, trends and development. Neural Regen Res 9(17):1643\u20131648. doi:10.4103\/1673-5374.141793","DOI":"10.4103\/1673-5374.141793"},{"issue":"4","key":"561_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2174\/157488811797904353","volume":"6","author":"JM Kaplan","year":"2011","unstructured":"Kaplan JM, Youd ME, Lodie TA (2011) Immunomodulatory activity of mesenchymal stem cells. Curr Stem Cell Res Ther 6(4):297\u2013316","journal-title":"Curr Stem Cell Res Ther"},{"key":"561_CR16","doi-asserted-by":"crossref","unstructured":"Sundin M, Ringden O, Sundberg B, Nava S, Gotherstrom C, Le Blanc K (2007) No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica 92(9):1208\u20131215","DOI":"10.3324\/haematol.11446"},{"issue":"1","key":"561_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0300-595X(84)80013-4","volume":"13","author":"DF Bowen-Pope","year":"1984","unstructured":"Bowen-Pope DF, Ross R (1984) Platelet-derived growth factor. Clin Endocrinol Metab 13(1):191\u2013205","journal-title":"Clin Endocrinol Metab"},{"issue":"8","key":"561_CR18","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1007\/BF02619199","volume":"16","author":"CT Eastment","year":"1980","unstructured":"Eastment CT, Sirbasku DA (1980) Human platelet lysate contains growth factor activities for established cell lines derived from various tissues of several species. In Vitro 16(8):694\u2013705","journal-title":"In Vitro"},{"key":"561_CR19","doi-asserted-by":"publisher","unstructured":"Muller I, Kordowich S, Holzwarth C, Spano C, Isensee G, Staiber A et al (2006) Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 8(5):437\u2013444. doi:10.1080\/14653240600920782","DOI":"10.1080\/14653240600920782"},{"key":"561_CR20","doi-asserted-by":"publisher","unstructured":"Lange C, Cakiroglu F, Spiess AN, Cappallo-Obermann H, Dierlamm J, Zander AR (2007) Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cellular Physiol 213(1):18\u201326. doi:10.1002\/jcp.21081","DOI":"10.1002\/jcp.21081"},{"key":"561_CR21","doi-asserted-by":"publisher","unstructured":"Schallmoser K, Bartmann C, Rohde E, Reinisch A, Kashofer K, Stadelmeyer E et al (2007) Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47(8):1436\u20131446. doi:10.1111\/j.1537-2995.2007.01220.x","DOI":"10.1111\/j.1537-2995.2007.01220.x"},{"key":"561_CR22","doi-asserted-by":"publisher","unstructured":"Capelli C, Domenghini M, Borleri G, Bellavita P, Poma R, Carobbio A et al (2007) Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transpl 40(8):785\u2013791. doi:10.1038\/sj.bmt.1705798","DOI":"10.1038\/sj.bmt.1705798"},{"key":"561_CR23","doi-asserted-by":"crossref","unstructured":"Carrancio S, Lopez-Holgado N, Sanchez-Guijo FM, Villaron E, Barbado V, Tabera S et al (2008) Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Experimental Hematol 36(8):1014\u20131021","DOI":"10.1016\/j.exphem.2008.03.012"},{"key":"561_CR24","doi-asserted-by":"publisher","unstructured":"Salvade A, Della Mina P, Gaddi D, Gatto F, Villa A, Bigoni M et al (2010) Characterization of platelet lysate cultured mesenchymal stromal cells and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects. Tissue Eng Part C 16(2):201\u2013214. doi:10.1089\/ten.TEC.2008.0572","DOI":"10.1089\/ten.TEC.2008.0572"},{"key":"561_CR25","doi-asserted-by":"crossref","unstructured":"Bieback K, Hecker A, Kocaomer A, Lannert H, Schallmoser K, Strunk D et al (2009) Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27(9):2331\u20132341","DOI":"10.1002\/stem.139"},{"key":"561_CR26","doi-asserted-by":"crossref","unstructured":"Crespo-Diaz R, Behfar A, Butler GW, Padley DJ, Sarr MG, Bartunek J et al (2011) Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability. Cell Transplant 20(6):797\u2013811","DOI":"10.3727\/096368910X543376"},{"key":"561_CR27","doi-asserted-by":"crossref","unstructured":"Xia W, Li H, Wang Z, Xu R, Fu Y, Zhang X et al (2011) Human platelet lysate supports ex vivo expansion and enhances osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. Cell Biol Int 35(6):639\u2013643","DOI":"10.1042\/CBI20100361"},{"key":"561_CR28","first-page":"33","volume":"129","author":"S Kinzebach","year":"2013","unstructured":"Kinzebach S, Bieback K (2013) Expansion of mesenchymal stem\/stromal cells under xenogenic-free culture conditions. Adv Biochem Eng Biotechnol 129:33\u201357","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"561_CR29","doi-asserted-by":"crossref","unstructured":"Warnke PH, Humpe A, Strunk D, Stephens S, Warnke F, Wiltfang J et al (2013) A clinically-feasible protocol for using human platelet lysate and mesenchymal stem cells in regenerative therapies. J Craniomaxillofac Surg 41(2):153\u2013161","DOI":"10.1016\/j.jcms.2012.07.003"},{"key":"561_CR30","doi-asserted-by":"crossref","unstructured":"Fekete N, Rojewski MT, Furst D, Kreja L, Ignatius A, Dausend J et al (2012) GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC. PloS One 7(8):e43255","DOI":"10.1371\/journal.pone.0043255"},{"key":"561_CR31","doi-asserted-by":"crossref","unstructured":"Bernardi M, Albiero E, Alghisi A, Chieregato K, Lievore C, Madeo D et al (2013) Production of human platelet lysate by use of ultrasound for ex vivo expansion of human bone marrow-derived mesenchymal stromal cells. Cytotherapy 15(8):920\u2013929","DOI":"10.1016\/j.jcyt.2013.01.219"},{"key":"561_CR32","doi-asserted-by":"crossref","unstructured":"Mojica-Henshaw MP, Jacobson P, Morris J, Kelley L, Pierce J, Boyer M et al (2013) Serum-converted platelet lysate can substitute for fetal bovine serum in human mesenchymal stromal cell cultures. Cytotherapy 15(12):1458\u20131468","DOI":"10.1016\/j.jcyt.2013.06.014"},{"key":"561_CR33","doi-asserted-by":"crossref","unstructured":"Shanskii YD, Sergeeva NS, Sviridova IK, Kirakozov MS, Kirsanova VA, Akhmedova SA et al (2013) Human platelet lysate as a promising growth-stimulating additive for culturing of stem cells and other cell types. Bull Exp Biol Med 156(1):146\u2013151","DOI":"10.1007\/s10517-013-2298-7"},{"key":"561_CR34","doi-asserted-by":"crossref","unstructured":"Iudicone P, Fioravanti D, Bonanno G, Miceli M, Lavorino C, Totta P et al (2014) Pathogen-free, plasma-poor platelet lysate and expansion of human mesenchymal stem cells. J Transl Med 12:28","DOI":"10.1186\/1479-5876-12-28"},{"key":"561_CR35","doi-asserted-by":"crossref","unstructured":"Shih DT, Burnouf T (2014) Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion. N Biotechnol","DOI":"10.1016\/j.nbt.2014.06.001"},{"key":"561_CR36","doi-asserted-by":"crossref","unstructured":"Centeno CJ, Schultz JR, Cheever M, Robinson B, Freeman M, Marasco W (2010) Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr Stem Cell Res Ther 5(1):81\u201393","DOI":"10.2174\/157488810790442796"},{"key":"561_CR37","doi-asserted-by":"crossref","unstructured":"Fekete N, Gadelorge M, Furst D, Maurer C, Dausend J, Fleury-Cappellesso S et al (2012) Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components. Cytotherapy 14(5):540\u2013554","DOI":"10.3109\/14653249.2012.655420"},{"key":"561_CR38","doi-asserted-by":"crossref","unstructured":"Abdelrazik H, Spaggiari GM, Chiossone L, Moretta L (2011) Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function. Eur J Immunol 41(11):3281\u20133290","DOI":"10.1002\/eji.201141542"},{"key":"561_CR39","doi-asserted-by":"crossref","unstructured":"Copland IB, Garcia MA, Waller EK, Roback JD, Galipeau J (2013) The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy. Biomaterials 34(32):7840\u20137850","DOI":"10.1016\/j.biomaterials.2013.06.050"},{"key":"561_CR40","doi-asserted-by":"crossref","unstructured":"Horn P, Bokermann G, Cholewa D, Bork S, Walenda T, Koch C et al (2010) Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells. Cytotherapy 12(7):888\u2013898","DOI":"10.3109\/14653249.2010.501788"},{"key":"561_CR41","doi-asserted-by":"crossref","unstructured":"Lohmann M, Walenda G, Hemeda H, Joussen S, Drescher W, Jockenhoevel S et al (2012) Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells. PloS One 7(5):e37839","DOI":"10.1371\/journal.pone.0037839"},{"key":"561_CR42","doi-asserted-by":"crossref","unstructured":"Hemeda H, Kalz J, Walenda G, Lohmann M, Wagner W (2013) Heparin concentration is critical for cell culture with human platelet lysate. Cytotherapy 15(9):1174-1181","DOI":"10.1016\/j.jcyt.2013.05.006"},{"key":"561_CR43","doi-asserted-by":"crossref","unstructured":"Secco M, Zucconi E, Vieira NM, Fogaca LL, Cerqueira A, Carvalho MD et al (2008) Multipotent stem cells from umbilical cord: cord is richer than blood! Stem Cells 26(1):146\u2013150","DOI":"10.1634\/stemcells.2007-0381"},{"key":"561_CR44","doi-asserted-by":"crossref","unstructured":"Ben Azouna N, Jenhani F, Regaya Z, Berraeis L, Ben Othman T, Ducrocq E et al (2012) Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum. Stem Cell Res Ther 3(1):6","DOI":"10.1186\/scrt97"}],"updated-by":[{"DOI":"10.1186\/s12967-025-06172-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000}}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-015-0561-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-015-0561-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-015-0561-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-015-0561-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T14:46:28Z","timestamp":1739198788000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-015-0561-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,17]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["561"],"URL":"https:\/\/doi.org\/10.1186\/s12967-015-0561-6","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12967-025-06172-4","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,17]]},"assertion":[{"value":"14 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12967-025-06172-4","URL":"https:\/\/doi.org\/10.1186\/s12967-025-06172-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"232"}}